Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells-Reference-Cited by-同舟云学术

Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells

Published:2019-01-03 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Wang Ying¹,Yang Bin²,Zhao Jinping²,Yu Xiaohui¹,Liu Xing¹,Zhang Long¹,Zhang Yunjing¹,Li Xiaoli¹,Zhai Zhenhua¹

Affiliation:

1. Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China

2. Laboratory of Tumor Angiogenesis and Microenvironment, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/8 signaling in human granulosa-lutein cells;Molecular and Cellular Endocrinology;2024-03

2. The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer;Clinical and Experimental Obstetrics & Gynecology;2023-12-26

3. Addition of heparin binding sites strongly increases the bone forming capabilities of BMP9 in vivo;Bioactive Materials;2023-11

4. Ovarian cancer, malignant ascites and microenvironment. Literature review;Sechenov Medical Journal;2023-08-14

5. Bone morphogenetic protein (BMP)9 in cancer development: mechanistic, diagnostic, and therapeutic approaches?;Journal of Drug Targeting;2023-07-19